Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000
The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE.
Medicamen Organics Limited (MOL) has secured a substantial order for Povidone Iodine 10 per cent Solution (US Extension), valued at Rs 6,28,15,000. This order encompasses 739,000 units of the product and highlights MOL's dedication to expanding its market reach and providing high-quality healthcare solutions. Povidone Iodine 10% Solution is a widely recognized antiseptic, and MOL is well-positioned to fulfil the increasing demand in this sector.
Medicamen Organics Limited (MOL) is a leading Indian pharmaceutical company specializing in the production and distribution of a diverse range of healthcare products. With a global presence, MOL is dedicated to innovation and quality in its offerings. Their extensive product portfolio includes essential medications for various ailments, such as antibacterial, antifungal, and antidiabetic drugs. MOL's commitment to accessibility is evident in its distribution network, reaching customers across India and in regions like Africa, the Commonwealth of Independent States (CIS), and Southeast Asia.
The Company is actively expanding its global footprint. A recent MoU with Depot Pharmacy Yego Limited in Rwanda has solidified its presence in East Africa, facilitating access to high-quality healthcare products in the region. Additionally, a strategic partnership with Mr. Vaibhav Kashinath Chaudhari and Mistycube Analytics has led to the formation of Grande Etoile Pharmaceuticals Ltd. This collaboration aims to establish a robust business in the French West Africa market through effective marketing strategies. MOL will hold a majority 51 per cent stake in GEPL, with an authorized capital of Rs 5 crore. GEPL will focus on registering its own branded products within the FWA market.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
For FY24, the company has reported total income of Rs 2,528.96 lakh with EBITDA of Rs 475.56 lakh & PAT of Rs 262.43 lakh. The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE.
Disclaimer: The article is for informational purposes only and not investment advice.